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Abstract
Sensitive methods for the determination of the cyclophosphamide metabolites nornitrogen mustard, 4- 
ketocyclophosphamide and carboxyphosphamide are presented. After liquid-liquid extraction and derivatization, 
the metabolites are determined by gas chromatography and thermionic specific detection. The methods were used 
to study the in vitro biotransformation of cyclophosphamide with S-9 liver fractions of human donors. The results 
show large interindividual differences in the formation of nornitrogen mustard and carboxyphosphamide. 4- 
Ketocyclophosphamide was not detected.
1. Introduction
Cyclophosphamide (CP) is an alkylating anti- 
neoplastic agent with activity against a variety of 
human tumours [1], CP is also used in the 
treatment of autoimmune diseases and during 
renal and bone marrow transplantations [1], The 
activity of CP is caused by its metabolites [1]. 
During bioactivation by hepatic cytochrome P- 
450, 4-hydroxycyclophosphamide is formed 
which is in equilibrium with its ring-opened 
tautomer aldophosphamide (Fig. 1). Both metab­
olites are detoxified by isoenzymes of the NAD- 
linked aldehyde dehydrogenase and aldehyde 
oxidase resulting in the formation of carboxy-
* Corresponding author.
phosphamide (CAR) and 4-ketocyclophos- 
phamide (KCP), respectively. ^-Elimination of 
acrolein from aldophosphamide yields phosphor- 
amide mustard, a directly active alkylating 
species which reacts with DNA. Cleavage of 
phosphoramide mustard results in the formation 
of nornitrogen mustard (NNM). Acrolein binds 
covalently to proteins. Most CP metabolites are 
ultimately eliminated by renal excretion.
In recently published studies, we have deter­
mined non-metabolised CP in urine samples of 
occupationally exposed hospital workers hand­
ling antineoplastic agents [2-5]. For the determi­
nation of low concentrations in urine a sensitive 
gas chromatographic-mass spectrometric meth­
od was developed [6]. In urine samples of many 
hospital workers CP was found. However, little is
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Fig. 1. Schematic presentation of the biotransformation of cyclophosphamide showing the most important reactions and 
metabolites (after Sladek [1]).
known about interindividual differences in bio­
transformation of this agent. Therefore, the in 
vitro biotransformation of CP was studied using 
(non)induced S-9 liver fractions. The rate of 
formation of the toxic metabolite NNM and the 
non-toxic metabolites KCP and CAR were mea­
sured. We were especially interested in the bal­
ance between toxiiication (NNM formation) and 
detoxification (KCP + CAR formation) which is 
expressed by the toxic/non-toxic metabolites 
ratio NNM /(KCP + CAR).
The number of chromatographic methods 
available for the monitoring of CP metabolites is 
limited [7], Therefore, new methods for the
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determination of KCR CAR and NNM OH, USA). All other chemicals were of the
2,2. H uman livers
bation mixtures are developed. After liquid—liq- highest purity obtainable, 
uid extraction and derivatization, the metabolites 
are determ ined with gas chromatography and 
thermionic specific detection. NNM was deter­
mined after derivatization with benzenesul- 
phonyl chloride. KCP and C A R  were deter- 
mined after derivatization with N,N-dimethyl-
formamide dimethyl acetal.
2. Experimental
2.1. Chemicals
CP, 4-hydroxyperoxycyclophosphamide, thro- 
phosphamide (TR O ), C A R  and KCP were 
gifts from  ASTA-Medica (Frankfurt am Main, 
Germany), Glucose-6-phosphate, sucrose and 
aniline were purchased from Sigma (St. Louis, 
MO, USA). 7-Ethoxy- and 7-pentoxyresorufin 
were from Boehringer (Mannheim, Germany). 
Nornitrogen mustard • HC1 (NNM) and resorufin 
were from  Aldrich (Milwaukee, WI, USA) and 
benzenesulphonyl chloride, E D T A  and 4-mor- 
pholinepropanesulphonic acid (MOPS), were 
obtained from Janssen Chimica (Beerse, Bel­
gium). N,N-dimethylformamide dimethyl acetal 
was purchased from Chrompack (Middelburg, 
Netherlands). N A D P was from USB (Cleveland,
Pieces of human donor livers were used. They 
were kindly obtained from Dr. W.H.M. Peters, 
Division of Gastrointestinal and Liver Diseases, 
University of Nijmegen, Netherlands. D onor 
livers were made available anonymously. Conse­
quently, limited information on the age and sex 
and no information about smoking and drinking 
habits was available. Their characteristics are 
presented in Table 1.
2.3, Preparation o f  the S-9  liver fractions
Liver homogenates were prepared (20%, w/v) 
in SETH-buffer (0.25 M  sucrose, 2 mM  E D T A  
and 10 mM  Tris-HCi, pH  = 7.4) with a Teflon- 
glass homogenizer. A fter centrifugation at 9000 g 
for 20 min, the floating fat layer was removed. 
The S-9 liver fraction was divided into a number 
of samples, frozen in liquid nitrogen and stored 
at -80°C  until use.
2.4. In vitro incubations
The frozen S-9 liver fractions were thawed 
quickly at 37°C immediately prior to use and 
kept on ice. The incubation mixture contained 44
TabJe 1
Total P-450 content, E R O D  and A H  activities in human S-9 liver fractions
Liver Sex Age Total P-450
(nmol m g ' 1 protein)
E R O D a
(pmol m in_i m g " 1 protein)
A H b
(pmol m in” 1 m g " 1 protein)
1 ?ct 9V 0.09 4.7 0.17
2 male 16 0.11 3.6 0.18
3 ?» 9» 0.09 3.7 0.13
4 9« 20 0.22 4.0 0.32
5 male 47 0.09 8.0 0.15
6 9è 9* 0.12 12.9 0.19
7 ? 9« 0.08 2.7 0.06
Mean ± S.D. 0.11 ±0.05 5.6 ± 3.6 0.17 ± 0.08
a 7-Ethoxyresorufin-O-deethyIase. 
b 4-Aniline-hydroxylase. 
c Sex and age are not known.
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mM  MOPS buffer pH = 7.4, 2 mM  NADP, 5 mM  
MgCl2 * 6H20 ,  2 mM  glucose-6-phosphate, 1 mM  
EDTA, and an amount of S-9 liver fraction 
based on 3.5 mg protein. After a preincubation 
of 5 min at 37°C, the incubation was started by 
adding 1,5 ¿¿mol CP. The final incubation volume 
was 1 ml. The mixture was mildly shaken during 
the (pre)incubation at 150 rpm. The incubation 
was stopped after 30 min by the addition of 75 jjl 1 
of a 6 M  HC1 solution. The reaction mixture was 
immediately cooled on ice-water. All incubations 
were carried out double in triplicate. One series 
in triplicate was used for the determination of 
CAR and KCP. The other was used for the 
determination of NNM.
2.5. Enzyme measurements
Total cytochrome P-450 was determined from 
the dithionite-difference spectrum according to 
Rutten et al. [8]. Protein concentrations were 
measured with the method of Bradford using 
crystalline bovine serum albumin as standard [9]. 
7-Ethoxyresorufin-O-deethylase (ER O D ) activi­
ty was determined according to Burke et al. [10] 
and 4-aniline-hydroxylase (AH) was measured 
according to Ishidate et al. [11]. Enzyme and 
total cytochrome P-450 measurements were per­
formed in duplicate and protein concentrations 
were measured in triplicate.
2.6. Sample preparation and gas 
chromatographic analysis o f  the 
cyclophosphamide metabolites
C AR and KCP
After the incubation was stopped, 45 ¡A 10 M  
NaOH and 100 fil 1 M  MOPS buffer pH = 8.0 
were added. Excess of CP was removed by 4 
extractions with 7 ml of diethyl ether by shaking 
for 5 min to avoid interference during the analy­
sis. The ether layers were discarded and 200 ¡A 6 
M  HC1 was added. The mixture was extracted 
twice with 4.5 ml ethyl acetate by shaking during 
5 min. The ethyl acetate layers were combined in 
conical tubes with screw caps and dried under 
nitrogen at 40°C. A fter addition of 700 fi\ 
toluene, 25 fi\ N,N-dimethylformamide dimethyl
acetal and subsequently mixing, the tubes were 
closed for derivatization for 35 min at 115°C. The 
samples were cooled to room temperature and 
dried again under nitrogen at 50°C. Thereafter 
200 ¿¿1 toluene, containing 1 /xg TRO (internal 
standard for controlling the sensitivity of the 
detector) was added, followed by sonification for 
5 min. A  l-/xl sample was injected.
Gas chromatography with thermionic specific 
detection was performed on a Varian 3400 GC 
that was controlled by a Varian GC Star Worksta­
tion on a Grid 386 personal computer. Samples 
were injected splitless. A 15-m DB-5 column 
(J&W, Folsom, CA, USA) was used with 0,32 
mm internal diameter and 0.25 fim  film thick­
ness. The injector temperature was 320°C. The 
initial oven temperature was 85°C. After 1 min, 
the temperature was increased to 280°C follow­
ing 4 segments (85~170°C, 20°C/min; 170-190aC, 
5°C/min; 190-210°C, 10°C/min; 210-280°C,
20°C/min) where it remained constant for 6 min. 
Helium was used as carrier gas [column inlet 
pressure 12 p.s.i. (ca. 8.2 * 102 Pa)]. The ther­
mionic specific detector was set at 300°C. For 
quantification the peak-area ratios CAR/TRO  
and KCP/TRO were calculated. Quantification 
of the CA R and KCP derivatives was carried out 
by reference to calibration curves constructed 
from the analysis of freshly prepared reference 
samples containing CAR (0, 5, 10, 20, and 25 
nmol) and KCP (0, 13, 26, 38, and 51 nmol) 
dissolved in a blank incubation mixture. The 
reference samples containing CAR and KCP 
underwent the whole sample preparation p ro ­
cedure.
N N M
The incubation was stopped after 15 s, and 45 
fi 1 10 M  NaOH and 100 fA 1 M  MOPS buffer 
pH = 8.0 were added. After 22 h at 37°C, 4.5 ml 
diethyl ether and 5 /xl benzenesulphonylchloride 
were added successively and the mixture was 
shaken during 90 min, and centrifuged during 5 
min at 2500 rpm (1500 g). The ether layers were 
removed and dried under nitrogen at 30°C, After 
addition of 1 ml water, the solution was extracted 
twice with 2 ml n-hexane. The hexane layers 
were removed and dried under nitrogen at 40°C.
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Finally, the extract was dissolved in 200 ¿¿1 
toluene containing 1 /¿g TRO (internal standard 
fo r  controlling the sensitivity of the detector). A  
l-jul sample was injected.
For the analysis of NNM the same equipm ent 
and  conditions were used as for the analysis of 
C A R  and KCP, except for the oven programme. 
T he initial oven tem perature was 85°C. A fter 1 
min, the temperature was increased by 15°C/min 
to  280°C, where it remained constant for 6 min. 
F o r  quantification the peak-area ratio N N M / 
T R O  was calculated. Quantification of the de- 
rivatized NNM and TR O  was carried out by 
reference to calibration curves constructed from  
th e  analysis of freshly prepared reference sam ­
ples containing 4-hydroxyperoxycyclophos- 
phamide (0, 25, 50, 100, and 200 nmol) dissolved 
in blank incubation mixtures. For the determ i­
nation of NNM we were not able to use cali- 
bration curves constructed from the analysis of 
freshly prepared reference samples containing 
NNM  itself. It appeared that NNM was no t 
formed within the incubation period but in a 
later stage out of metabolites generated during 
the incubation (Fig. 1). Therefore, the incubation 
mixture was put at 37°C during 22 h and 4- 
hydroxyperoxycyclophosphamide, which was 
completely converted to NNM, was preferred for 
the  construction of the calibration curve instead 
o f  NNM itself.
Statistical analysis
Statistical analysis was carried out on a person™ 
al computer using InStat 1.1 as software package. 
Correlations were quantified with the Pearson 
correlation coefficient r, P-values (two-tailed) 
below 0.05 were considered to be of statistical 
significance.
3. Results and discussion
We have developed methods for the determ i­
nation of the CP metabolites KCP, C A R  and 
NNM in incubation mixtures. Prior to analysis, 
KCP and CAR were extracted from the incuba­
tion mixture with ethyl acetate and m ethylated 
with N,N-dimethylformamide dimethyl acetal.
Fig. 2 shows typical chromatograms of derivat- 
ized extracts of a blank incubation mixture 
spiked with KCP, CA R and TRO  (internal 
standard) (A); a blank incubation mixture spiked 
with TRO  (B); and an incubation mixture con­
taining a S-9 fraction of a human donor liver (C). 
The retention times of KCP, CP, CAR, and TR O  
were 6.8 , 6.9, 7.2 and 8.9 min, respectively. The 
C.V. of the retention times was below 0.7%. In 
order to quantify the amount of KCP exactly, it 
was necessary to remove excess of CP. This was 
done by four extractions with diethyl ether prior 
to the extraction of the acidified incubation 
mixture with ethyl acetate. Finally, KCP and CP 
were completely separated and no interference 
with other compounds was observed. NNM was 
derivatized with benzenesulphonylchloride in di­
ethyl ether according to the so-called Hinsberg- 
test resulting in the formation of a sulphonamide 
[12]. Fig. 3 shows typical chromatograms of 
derivatized extracts of a blank incubation mix­
ture spiked with NNM (in situ formed out of 
4-hydroxyperoxycyclophosphamide) and TRO  
(internal standard) (A); a blank incubation mix­
ture spiked with TRO (B); and an incubation 
mixture containing a S-9 fraction of a human 
donor liver (C). The retention times of NNM, 
CP, and T R O  were 7.6, 7.8 and 9.0 min, respec­
tively. The C.V of the retention times was below
0.2%). No interference of NNM, CP and TRO  
with other compounds was observed. All cali­
bration curves were linear, with a coefficient of 
correlation of a least 0.99. The limits of detection 
for CAR, KCP and NNM were 0.5, 0.5 and 0.1 
nm ol/m l incubation mixture (2.5, 2.5 and 0.5 
pmol on column). The intra-assay precision 
(mean relative standard deviation of all triplicate 
incubations) was about 9% for NNM and 16% 
for CAR. The recovery of the extraction pro­
cedures is almost 100%.
Large differences in total P-450 content and 
E R O D  and A H  activities were observed among 
the liver fractions of the donors (Table 1). Total 
P-450 content ranged from 0.08 to 0.22 nmol/mg 
protein. E R O D  and A H  activity ranged from 2.7 
to 12.9 and from 0.06 to 0.32 pm ol/m in per mg 
protein, respectively. Large differences were also 
found in NNM, CAR and total metabolite for-
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Fig. 2. Chromatograms of ethyl acetate extracts of incubation mixtures after derivatization with N,N-dimethylformamide dimethyl 
acetal, Peaks (retention time): KCP = 4-ketocyclophosphamide (6.8 min); CP = cyclophosphamide (6.9 min); CAR = 
carboxyphosphamide (7.2 min); TRO = trophosphamide (internal standard) (8.9 min). (A) Blank incubation mixture spiked with 
KCP (26 nmol /ml incubation mixture), CAR (10 nmol/ml incubation mixture) and TRO (15 nmol/ml toluene). (B) Blank 
incubation mixture spiked with TRO (15 nmol/ml toluene). (C) Incubation mixture containing S-9 liver fractions of liver 4.
mation and NNM /CAR ratio after incubation of 
CP with human S-9 liver fractions (Table 2). In 
none of the incubation mixtures KCP was de­
tected. The highest amount of NNM was formed 
by liver 1. The NNM formation rate was eight 
times higher when compared to liver 7, having 
the lowest NNM formation rate. Liver 4 showed 
the highest CAR formation rate. This was fifteen 
times higher when compared to liver 6, having 
the lowest rate. Liver 4 also showed the highest 
NNM + CAR formation rate. This was eight 
times higher when compared to liver 6 with the 
lowest NNM + CAR formation. Liver 1 showed 
the highest NNM /CAR ratio. This was four 
times higher when compared to liver 4, the 
lowest one. It should be mentioned that the 
livers 1 and 4 with the highest NNM + CAR 
formation differed substantially in NNM/CAR
ratio. Comparable results were found for the 
livers 6 and 7 with the lowest NNM + CAR 
formation.
The results show large differences in the bio­
transformation of CP. Comparable results were 
found by Chang et al. although microsomes of 
human donor livers were used instead of S-9 liver 
fractions as was done in our study [13], Besides, 
they studied CP 4-hydroxylase activity fluoro- 
metrically while we have determined CP metabo­
lites with gas chromatography. They found that 
P-4501A1,1A2 and 2E1 did not contribute to the 
hydroxylation of CP. In our study, we did not 
find a correlation between ERO D  (P-4501A1) 
activity and NNM, CAR, total metabolite forma­
tion and the NNM /CAR ratio. On the contrary, 
we found a correlation between CAR and total 
metabolite formation and A H  (P-4502E1) activi-
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om atogram s of diethyl ether extracts of incubation mixtures after derivatization with benzenesulphonylchloride. Peaks 
time): NNM =  nornitrogen mustard (7,6 min); CP =  cyclophosphamide (7.8 min); T R O  =  trophospham ide (internal 
(9.0 min). (A) Blank incubation mixture spiked with NNM (100 nm ol/m l incubation mixture) and T R O  (15 nm ol/m l 
B ) Blank incubation mixture spiked with TRO (15 nmol/ml toluene). (C) Incubation mixture containing S-9 liver 
>f liver 7.
18373, P  =  0.0187 and r =  0.7954, P =
respectively). NNM formation and the 
!A R ratio were not correlated. Unfor­
tunately, it is not possible to establish the causal 
factor of the large differences in E R O D  and A H  
activity between the individual hum an S-9 liver
t o f NNM and CAR after incubation of cyclophosphamide with human S-9 liver fractions“
NNM CAR NNM + CAR N N M /C A R  ratio
89 39 128 2.3
40 21 61 1.9
18 14 32 1.3
69 117 186 0.6
22 23 (n -  2) 45 1.0
15
r?113,
00 23 1.9
n 14 25 0.8
.D. 38 ±31 34 ± 3 8 71 ±  61 1.4 ±0.7
f  N N M  and CA R formation are means ± S.D. of duplicate (n -  2 ) o r triplicate incubations (pm ol/m in  per mg protein).
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preparations since no more data of the donors 
was available. Enhanced activity of E R O D  and 
A H  do not per se reflect the induction of specific 
enzymes caused, for instance, by the life style 
factors smoking or alcohol Genetic factors may 
also be of importance with respect to P-450 
isoenzyme activities involved in the biotransfor­
mation of CP.
The large interindividual differences in espe­
cially the formation of NNM and C A R  and the 
N N M /C A R  ratio between the liver S-9 samples 
suggest large interindividual differences in the 
toxicity of CP due to differences in biotrans­
formation. A  high N N M /C A R  ratio may be 
predictive for a relatively high level of DNA- 
alkylating metabolites in vivo. Otherwise a low 
N N M /C A R  ratio may be predictive for the 
formation of detoxified metabolites.
We may assume that comparable differences in 
biotransformation will occur in man in vivo, for 
instance in treated patients and in occupationally 
exposed workers. This means that it is not 
possible to estimate the exact individual dose of 
CP in occupationally exposed workers on basis of 
their individual urinary excretion of CP. T here­
fore, we have applied the developed methods for 
the determination of KCP, C A R  and NNM in 
urine of hospital workers. Unfortunately, the 
methods were not appropriate because we were 
not able to extract the metabolites and to de- 
rivatize them. Hence, only the method for the 
determination of CP in urine of hospital workers 
can be used to establish occupational exposure to 
CP and to estimate a group-based exposure level.
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